Letter by bishu regarding article, effect of pulmonary hypertension hemodynamic presentation on clinical outcomes in patients with severe symptomatic aortic valve stenosis undergoing transcatheter aortic valve implantation: Insights from the new proposed pulmonary hypertension classification

Circulation: Cardiovascular Interventions

Volumn 8, Issue 9, 2015, Pages

  Bishu, Kalkidan ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA VALVE STENOSIS; CARDIAC PATIENT; CARDIOVASCULAR MORTALITY; ECHOCARDIOGRAPHY; HEART CATHETERIZATION; HEART LEFT VENTRICLE CONTRACTION; HUMAN; LETTER; LUNG ARTERY PRESSURE; LUNG HEMODYNAMICS; OUTCOME ASSESSMENT; PH; PRIORITY JOURNAL; PULMONARY HYPERTENSION; TRANSCATHETER AORTIC VALVE IMPLANTATION; AORTIC VALVE STENOSIS; CLASSIFICATION; FEMALE; HEART VALVE REPLACEMENT; MALE; PROCEDURES;

AORTIC VALVE STENOSIS; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; HYPERTENSION, PULMONARY; MALE; TRANSCATHETER AORTIC VALVE REPLACEMENT;

EID: 84957677186     PISSN: 19417640     EISSN: 19417632     Source Type: Journal    
DOI: 10.1161/CIRCINTERVENTIONS.115.003047     Document Type: Letter

References (5)

1. O'Sullivan CJ, Wenaweser P, Ceylan O, Rat-Wirtzler J, Stortecky S, Heg D, Spitzer E, Zanchin T, Praz F, Tüller D, Huber C, Pilgrim T, Nietlispach F, Khattab AA, Carrel T, Meier B, Windecker S, Buellesfeld L., Effect of pulmonary hypertension hemodynamic presentation on clinical outcomes in patients with severe symptomatic aortic valve stenosis undergoing transcatheter aortic valve implantation: insights from the new proposed pulmonary hypertension classification. Circ Cardiovasc Interv 2015 8 e002358. doi: 10.1161/CIRCINTERVENTIONS.114.002358
2. Ben-Dor I, Goldstein SA, Pichard AD, Satler LF, Maluenda G, Li Y, Syed AI, Gonzalez MA, Gaglia MA Jr, Wakabayashi K, Delhaye C, Belle L, Wang Z, Collins SD, Torguson R, Okubagzi P, Aderotoye A, Xue Z, Suddath WO, Kent KM, Epstein SE, Lindsay J, Waksman R., Clinical profile, prognostic implication, and response to treatment of pulmonary hypertension in patients with severe aortic stenosis. Am J Cardiol 2011 107 1046 1051. doi: 10.1016/j.amjcard.2010.11.031
3. Bishu K, Suri RM, Nkomo VT, Kane GC, Greason KL, Reeder GS, Mathew V, Holmes DR, Rihal CS, Melduni RM., Prognostic impact of pulmonary artery systolic pressure in patients undergoing transcatheter aortic valve replacement for aortic stenosis. Am J Cardiol 2014 114 1562 1567. doi: 10.1016/j.amjcard.2014.08.019
4. Bishu K, Ogut O, Kushwaha S, Mohammed SF, Ohtani T, Xu X, Brozovich FV, Redfield MM., Anti-remodeling effects of rapamycin in experimental heart failure: dose response and interaction with angiotensin receptor blockade. PLoS One 2013 8 e81325. doi: 10.1371/journal.pone.0081325
5. Smith RC, Burchell HB, Edwards JE., Pathology of the pulmonary vascular tree. IV. Structural changes in the pulmonary vessels in chronic left ventricular failure. Circulation 1954 10 801 808. doi: 10.1161/01.CIR.10.6.801